PCN101 COST EFFECTIVENESS ANALYSIS COMPARING ENZALUTAMIDE, ABIRATERONE PLUS PREDNISONE AND CABAZITAXEL PLUS PREDINSONE FOR THE TREATMENT OF VISCERAL METASTATIC CASTRATION RESISTANT PROSTATE CANCER (MCRPC) POST DOCETAXEL FAILURE

Saved in:
Bibliographic Details
Published in:Value in health 2019-05, Vol.22, p.S75-S75
Main Authors: Barqawi, Y., Borrego, M., Roberts, M., Abraham, I.
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1098-3015
1524-4733
DOI:10.1016/j.jval.2019.04.225